Researchers at the University of Illinois at Chicago and Queensland University of Technology of Australia, have developed a device that can isolate individual cancer cells from patient blood samples.
The microfluidic device works by separating the various cell types found in blood by their size. The device may one day enable rapid, cheap liquid biopsies to help detect cancer and develop targeted treatment plans. The findings are reported in the journal Microsystems & Nanoengineering.
“This new microfluidics chip lets us separate cancer cells from whole blood or minimally-diluted blood,” said Ian Papautsky, the Richard and Loan Hill Professor of Bioengineering in the UIC College of Engineering and corresponding author on the paper. “While devices for detecting cancer cells circulating in the blood are becoming available, most are relatively expensive and are out of reach of many research labs or hospitals. Our device is cheap, and doesn’t require much specimen preparation or dilution, making it fast and easy to use.”
The ability to successfully isolate cancer cells is a crucial step in enabling liquid biopsy where cancer could be detected through a simple blood draw. This would eliminate the discomfort and cost of tissue biopsies which use needles or surgical procedures as part of cancer diagnosis. Liquid biopsy could also be useful in tracking the efficacy of chemotherapy over the course of time, and for detecting cancer in organs difficult to access through traditional biopsy techniques, including the brain and lungs.
However, isolating circulating tumor cells from the blood is no easy task, since they are present in extremely small quantities. For many cancers, circulating cells are present at levels close to one per 1 billion blood cells. “A 7.5-milliliter tube of blood, which is a typical volume for a blood draw, might have ten cancer cells and 35-40 billion blood cells,” said Papautsky. “So we are really looking for a needle in a haystack.”
Microfluidic technologies present an alternative to traditional methods of cell detection in fluids. These devices either use markers to capture targeted cells as they float by, or they take advantage of the physical properties of targeted cells — mainly size — to separate them from other cells present in fluids.
Papautsky and his colleagues developed a device that uses size to separate tumor cells from blood. “Using size differences to separate cell types within a fluid is much easier than affinity separation which uses ‘sticky’ tags that capture the right cell type as it goes by,” said Papautsky. “Affinity separation also requires a lot of advanced purification work which size separation techniques don’t need.”
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- Fingerprick PSA Test Has In-Office Results in 12 Minutes on April 17, 2019 at 11:34 am
The Sangia test quantitatively measures total PSA in capillary whole blood. The test is approved to be used with digital rectal examination (DRE) to screen for prostate cancer in men aged 50 years or ... […]
- Breast Cancer Screening Test Market: Worldwide Insight & Projection, 2019-2024 - ResearchAndMarkets.com on April 17, 2019 at 8:20 am
The breast cancer screening test market is expected to register a ... This is increasing the global demand for mammography while laboratory and blood tests and other imaging tests are gaining ... […]
- Breast cancer blood test could help to spot relapse earlier on April 17, 2019 at 7:50 am
A simple blood test could help to detect breast cancer relapse up to two years earlier than imaging in patients with early-stage breast cancer. In a small study, carried out by the University of ... […]
- Simple blood test can spot if breast cancer will return up to TWO YEARS earlier than current scans, finds study on April 16, 2019 at 9:58 pm
A simple blood test could accurately detect a breast-cancer survivor's risk of the disease returning, research suggests. A study that looked for a cancer marker in the blood of nearly 50 patients ... […]
- Simple blood test spots the return of breast cancer years earlier than current scans, study shows on April 16, 2019 at 5:45 pm
It detected 89 per cent of all recurrences sooner than scans such as mammograms Researchers took samples from 49 patients every six months for up to four years after surgery and chemotherapy. The ... […]
- Scientists test CRISPR gene editing on 2 U.S. cancer patients on April 16, 2019 at 12:18 pm
One patient was diagnosed with multiple myeloma, a form of cancer that affects plasma cells in the blood; the other was ... in order to test the efficiency of the CRISPR method in treating various ... […]
- The study of a cancer test seemed like a triumph. But some data were missing on April 12, 2019 at 1:58 am
this test combines a few different measurements of blood proteins into one number, which studies showed to be significantly better than the usual PSA results at identifying whether a man did, in fact, ... […]
- Researchers developing blood-based colon cancer test on April 11, 2019 at 9:24 pm
Scientists at UW-Madison have discovered four new blood-based markers for colon cancer, which they say could lead to a new blood test for the cancer. A study published this week in the scientific ... […]
- Dogs Can Accurately Sniff Out Lung Cancer in Human Blood: Study on April 10, 2019 at 11:30 am
Researchers hope to continue their work and create screening methods that can test for other life-threatening ... breast cancer study in which dogs attempt to smell cancer in breath samples instead of ... […]
- Blood test flags colon cancer warning signs on April 10, 2019 at 5:14 am
PHOENIX (3TV/CBS 5) --Few medical tests are more dreaded than a colonoscopy, but making sure your colon is healthy is important. That is why Sonora Quest labs has developed a blood test to look for ... […]
via Bing News